In this study, we sought to test the efficacy of AAV-mediated APN expression in AD-related pathology including amyloid deposition, microglial-mediated neuroinflammation, and dystrophic neurites observed in APP and PSEN1 transgenic mice with 5 AD-linked mutations. Here, ANPEP is linked to Alzheimer disease.